Suppression of hyperemia and DNA oxidation by indomethacin in cerebral ischemia

Eur J Pharmacol. 2003 Jan 17;459(2-3):179-86. doi: 10.1016/s0014-2999(02)02876-5.

Abstract

We investigated antioxidative activity and the effect of indomethacin, an agent that inhibits cyclooxygenase, on extracellular glutamate and cerebral blood flow in cerebral ischemia in gerbils. Pre-ischemic administration of indomethacin (5 mg/kg, i.p.) significantly rescued hippocampal CA1 neurons (9+/-6 cells/mm in the ischemia, 87+/-43 cells/mm in the indomethacin group, P<0.001). DNA fragmentation induced by ischemia was also examined using the terminal deoxynucleotidyl transferase-mediated UTP nick end labeling (TUNEL) method and indomethacin reduced TUNEL positive cells (140+/-21 in the ischemia, 99+/-31 in the indomethacin group, P<0.01). In addition, indomethacin attenuated the increase in hippocampal blood flow during reperfusion, but not increased extracellular glutamate by ischemia. Eight-hydroxydeoxyguanosine (8-OH-dG), a highly sensitive marker of DNA oxidation, was measured 90 min following ischemia using high-pressure liquid chromatography. Indomethacin significantly decreased the level of ischemia-induced 8-OH-dG in the hippocampus (P<0.05). These results suggest that indomethacin may protect neurons by attenuating oxidative stress and reperfusion injury in ischemic insult.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Cell Count / methods
  • Cell Death / drug effects
  • Cell Death / physiology
  • DNA / antagonists & inhibitors
  • DNA / metabolism*
  • DNA Damage / drug effects*
  • DNA Damage / physiology
  • Gerbillinae
  • Hyperemia / drug therapy*
  • Hyperemia / metabolism
  • Indomethacin / pharmacology
  • Indomethacin / therapeutic use*
  • Male
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology

Substances

  • DNA
  • Indomethacin